Brief: Vigil Neuroscience Q1 EPS USD -0.5 Vs. IBES Estimate USD -0.61
May 07 (Reuters) - Vigil Neuroscience Q1 operating expenses USD 21.415 million. * Q1 operating income USD -21.415 million vs. IBES estimate USD -24.5 million * Q1 net income USD -19.94 million vs. IBES estimate USD -23.6 million
Recent news on Vigil Neuroscience
See all newsVigil Neuroscience Inc reports results for the quarter ended June 30 - Earnings Summary
Vigil Neuroscience Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
U.S. RESEARCH ROUNDUP-Ralph Lauren, Vigil Neuroscience, Workday
Deals of the day-Mergers and acquisitions